SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 156.24+0.5%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Craig A who wrote (958)5/9/1999 10:38:00 AM
From: JEB  Read Replies (1) of 1686
 
This quarter's 10Q results: (Note the EU figures, you were right Harold!)

companysleuth.com

RESULTS OF OPERATIONS
For the quarter ended March 31, 1999, the Company reported net income of $45.7
million or $0.58 per diluted share as compared to $27.8 million or $0.36 per
diluted share for the comparable period of 1998.
Total revenues for the current quarter were $171.7 million, as compared to
$114.5 million in the quarter ended March 31, 1998, an increase of $57.2 million
or 50%. The increase in total revenues was primarily due to increased sales of
the Company's product AVONEX(R). Product sales for the current quarter were
$131.3 million compared to $76.1 million for the comparable period in 1998, an
increase of $55.2 million or 73%. The growth in the first quarter of 1999 was
primarily due to an increase in the sales volume of AVONEX(R) in the United
States and in the European Union ("EU"). AVONEX(R) sales outside of the United
States were approximately $36 million in the current quarter as compared to
approximately $13 million in the comparable period of 1998. Revenues from
royalties for the current quarter were $40.4 million as compared to $38.4
million for the comparable period of 1998, an increase of $2 million or 5%,
primarily as a result of an increase in royalties on sales of hepatitis B
vaccines and alpha interferon.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News